Jiangsu Hengrui Pharmaceuticals announcement on the progress of the 2024 quality improvement and efficiency increase return action plan.
Announcement from Jiangsu Hengrui Pharmaceuticals on its subsidiary passing the pharmaceutical GMP compliance inspection.
Announcement of Jiangsu Hengrui Pharmaceuticals' Subsidiary Receiving Drug Clinical Trial Approval Notice
Announcement of Jiangsu Hengrui Pharmaceuticals' Subsidiary Receiving Drug Clinical Trial Approval Notice
Announcement from Jiangsu Hengrui Pharmaceuticals regarding the public listing of its subsidiary's drug as a breakthrough therapy.
Announcement of Jiangsu Hengrui Pharmaceuticals' Subsidiary Receiving Drug Clinical Trial Approval Notice
Hengrui Pharmaceutical's Announcement on Subsidiaries Obtaining Approval Notices for Drug Clinical Trials
Hengrui Pharmaceutical's Announcement on Subsidiaries Obtaining Approval Notices for Drug Clinical Trials
Hengrui Pharmaceutical's Announcement on Subsidiaries Obtaining Approval Notices for Drug Clinical Trials
Hengrui Pharmaceutical's announcement on subsidiary drugs to be included in the list of breakthrough treatment varieties
Hengrui Pharmaceutical's Announcement on Subsidiaries Obtaining Approval Notices for Drug Clinical Trials
Hengrui Pharmaceutical's announcement on the shareholding status of the top ten shareholders and the top ten shareholders with unlimited sales conditions in the share repurchase matter
Hengrui Pharmaceutical's Announcement on Subsidiaries Obtaining Approval Notices for Drug Clinical Trials
Hengrui Pharmaceutical received a complete response letter from the US FDA regarding injectable carelizumab
Hengrui Pharmaceutical's Announcement on Signing a License Agreement and Foreign Investment
Announcement of Resolutions of Hengrui Pharmaceutical's 2023 Annual General Meeting of Shareholders
Legal Opinion of Hengrui Pharmaceutical's 2023 Annual General Meeting of Shareholders
Hengrui Pharmaceutical's Announcement on Subsidiaries Obtaining Approval Notices for Drug Clinical Trials
Hengrui Pharmaceutical's Announcement on Subsidiaries Obtaining Approval Notices for Drug Clinical Trials
Hengrui Pharmaceutical's Announcement on Subsidiaries Obtaining Approval Notices for Drug Clinical Trials
No Data